Total Payments
$257,147
2024 Payments
$22,919
Companies
42
Transactions
729
Medicare Patients
6,364
Medicare Billing
$603,821
Payment Breakdown by Category
Consulting$125,608 (48.8%)
Travel$53,869 (20.9%)
Other$53,780 (20.9%)
Food & Beverage$23,718 (9.2%)
Education$163.29 (0.1%)
Gifts$10.16 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $125,608 | 62 | 48.8% |
| Travel and Lodging | $53,869 | 144 | 20.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,145 | 17 | 16.8% |
| Food and Beverage | $23,718 | 496 | 9.2% |
| Honoraria | $10,500 | 5 | 4.1% |
| Education | $163.29 | 2 | 0.1% |
| Grant | $134.90 | 2 | 0.1% |
| Gift | $10.16 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $66,539 | 116 | $0 (2024) |
| Ra Medical Systems, Inc. | $32,930 | 42 | $0 (2022) |
| Cardinal Health 200 LLC | $27,004 | 31 | $0 (2021) |
| CORDIS US CORP. | $18,087 | 20 | $0 (2024) |
| Edwards Lifesciences Corporation | $12,229 | 11 | $0 (2023) |
| Terumo Medical Corporation | $9,302 | 19 | $0 (2024) |
| Getinge USA Sales, LLC | $9,263 | 7 | $0 (2023) |
| Abbott Laboratories | $8,671 | 78 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $8,452 | 8 | $0 (2023) |
| Maquet Cardiovascular U.S. Sales, L.L.C. | $7,886 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,919 | 67 | Boston Scientific Corporation ($13,051) |
| 2023 | $57,241 | 87 | Boston Scientific Corporation ($26,893) |
| 2022 | $38,141 | 100 | Boston Scientific Corporation ($6,702) |
| 2021 | $34,542 | 93 | Ra Medical Systems, Inc. ($17,969) |
| 2020 | $33,343 | 93 | Cardinal Health 200 LLC ($14,126) |
| 2019 | $36,218 | 115 | Cardinal Health 200, LLC ($9,377) |
| 2018 | $17,076 | 98 | Medtronic Vascular, Inc. ($4,801) |
| 2017 | $17,667 | 76 | The Spectranetics Corporation ($6,200) |
All Payment Transactions
729 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Datascope Corp. | MEGA 7.5Fr. 40cc IAB with Accessories (APA), US Only (Device) | Food and Beverage | In-kind items and services | $106.55 | General |
| Category: Medical Device | ||||||
| 12/14/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $45.16 | General |
| Category: AVVIGO_IC | ||||||
| 12/14/2024 | Datascope Corp. | MEGA 7.5Fr. 40cc IAB with Accessories (APA), US Only (Device) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Medical Device | ||||||
| 12/12/2024 | Endologix LLC | Torus Stent Graft System (Device), ENDOCROSS Device | Food and Beverage | In-kind items and services | $1,010.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.27 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/22/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.56 | General |
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $139.21 | General |
| Category: General - Vascular Intervention_PI | ||||||
| 09/08/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $217.58 | General |
| Category: General - Therapies_IC | ||||||
| 09/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $111.78 | General |
| Category: General - Therapies_IC | ||||||
| 09/06/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $539.42 | General |
| Category: General - Therapies_IC | ||||||
| 09/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $267.05 | General |
| Category: General - Therapies_IC | ||||||
| 09/06/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $228.90 | General |
| Category: General - Therapies_IC | ||||||
| 09/06/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $163.72 | General |
| Category: General - Therapies_IC | ||||||
| 09/06/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $20.61 | General |
| Category: General - Therapies_IC | ||||||
| 08/26/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $110.43 | General |
| Category: Endovascular | ||||||
| 08/21/2024 | Terumo Medical Corporation | GLIDESHEATH SLENDER (Device) | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| Category: LESION ACCESS | ||||||
| 08/21/2024 | Terumo Medical Corporation | GLIDESHEATH SLENDER (Device) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: LESION ACCESS | ||||||
| 08/15/2024 | Boston Scientific Corporation | ELUVIA (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: ELUVIA_PI | ||||||
| 08/15/2024 | Boston Scientific Corporation | ELUVIA (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: ELUVIA_PI | ||||||
| 08/13/2024 | Boston Scientific Corporation | — | Grant | In-kind items and services | $67.06 | General |
| Category: General - Therapies_IC | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $1.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.32 | General |
| 07/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,297 | 1,783 | $339,312 | $121,750 |
| 2022 | 31 | 1,423 | 1,974 | $453,440 | $142,011 |
| 2021 | 37 | 1,695 | 2,350 | $509,498 | $164,910 |
| 2020 | 37 | 1,949 | 2,586 | $561,020 | $175,150 |
Total Patients
6,364
Total Services
8,693
Medicare Billing
$603,821
Procedure Codes
137
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 271 | 416 | $91,520 | $37,192 | 40.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 158 | 275 | $34,759 | $16,921 | 48.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 48 | 48 | $29,168 | $9,228 | 31.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 18 | 21 | $25,539 | $8,909 | 34.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 79 | 79 | $18,012 | $7,988 | 44.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $13,110 | $5,390 | 41.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 36 | $12,260 | $4,893 | 39.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 45 | $8,135 | $4,197 | 51.6% |
| 37228 | Balloon dilation of artery of leg, initial vessel | Facility | 2023 | 11 | 12 | $15,146 | $3,811 | 25.2% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 21 | 22 | $10,844 | $3,182 | 29.3% |
| 36246 | Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | Facility | 2023 | 15 | 15 | $23,756 | $2,866 | 12.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2023 | 63 | 72 | $5,709 | $2,095 | 36.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 56 | 56 | $4,487 | $1,615 | 36.0% |
| 75710 | Review by radiologist of arm or leg artery image | Facility | 2023 | 22 | 23 | $4,577 | $1,472 | 32.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 23 | 23 | $2,950 | $1,454 | 49.3% |
| 75716 | Review by radiologist of both arms or legs arteries image | Facility | 2023 | 16 | 19 | $4,199 | $1,361 | 32.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 107 | 128 | $12,902 | $1,240 | 9.6% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 46 | 47 | $3,265 | $1,194 | 36.6% |
| 75625 | Review by radiologist of abdominal aorta image | Facility | 2023 | 19 | 22 | $2,992 | $1,147 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 13 | $2,860 | $991.51 | 34.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 14 | 15 | $2,642 | $972.30 | 36.8% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 28 | 120 | $2,924 | $898.00 | 30.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 20 | 23 | $1,575 | $892.86 | 56.7% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2023 | 43 | 45 | $2,018 | $695.19 | 34.4% |
| 93922 | Ultrasound study of arm and leg arteries | Facility | 2023 | 56 | 57 | $1,425 | $499.79 | 35.1% |
About Dr. Mohammad Ansari, M.D
Dr. Mohammad Ansari, M.D is a Internal Medicine healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1073762084.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Ansari, M.D has received a total of $257,147 in payments from pharmaceutical and medical device companies, with $22,919 received in 2024. These payments were reported across 729 transactions from 42 companies. The most common payment nature is "Consulting Fee" ($125,608).
As a Medicare-enrolled provider, Ansari has provided services to 6,364 Medicare beneficiaries, totaling 8,693 services with total Medicare billing of $603,821. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Lubbock, TX
- Active Since 09/15/2008
- Last Updated 11/22/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073762084
Products in Payments
- DABRA 101 Catheter (Device) $21,642
- ELUVIA (Device) $16,221
- Mynx Ace Vascular Closure Device (Device) $12,104
- General - Therapies (Device) $10,716
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $9,561
- GENERAL - VASCULAR INTERVENTION (Device) $7,205
- DABRA (Device) $6,506
- HawkOne (Device) $5,155
- (6361) Core Mobile (Device) $4,259
- Omnilink Elite vascular stent system (Device) $4,225
- FLOWMET (Device) $4,200
- Aggrastat (Drug) $4,000
- CVX-300CVX-300P (Device) $3,836
- CARDIOSAVE HYBRID, TYPE B PLUG (Device) $3,820
- RADIAL 360 (Device) $3,788
- MYNX CONTROL (Device) $3,769
- Cardiohelp (Device) $3,600
- GLIDESHEATH SLENDER (Device) $3,600
- ASAHI Peripheral Guide Wire (Device) $3,407
- EkoSonic (Device) $3,302
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lubbock
Mohammed Bakdash, M.d, M.D
Internal Medicine — Payments: $241,102
Internal Medicine $241,102
Sharma Prabhakar, M.d, M.D
Internal Medicine — Payments: $47,803
Internal Medicine $47,803
Dr. Joseph Wolcott, M.d, M.D
Internal Medicine — Payments: $37,371
Internal Medicine $37,371
Jose Suarez, Md, MD
Internal Medicine — Payments: $36,074
Internal Medicine $36,074
Dr. Michael Mcpherson, Md, MD
Internal Medicine — Payments: $30,601
Internal Medicine $30,601
Scott Shurmur, Md, MD
Internal Medicine — Payments: $21,697
Internal Medicine $21,697